Supplementary Table 3 from Temporal Muscle Thickness as a Prognostic Marker in Patients with Newly Diagnosed Glioblastoma: Translational Imaging Analysis of the CENTRIC EORTC 26071–22072 and CORE Trials

MLA

Matthias Preusser, et al. Supplementary Table 3 from Temporal Muscle Thickness as a Prognostic Marker in Patients with Newly Diagnosed Glioblastoma: Translational Imaging Analysis of the CENTRIC EORTC 26071–22072 and CORE Trials. Mar. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.22483050.v1.

APA

Matthias Preusser, Roger Stupp, Joerg C. Tonn, David A. Reardon, Burt Nabors, Thierry Gorlia, Michael Weber, Michael Weller, & Julia Furtner. (2023). Supplementary Table 3 from Temporal Muscle Thickness as a Prognostic Marker in Patients with Newly Diagnosed Glioblastoma: Translational Imaging Analysis of the CENTRIC EORTC 26071–22072 and CORE Trials. https://doi.org/10.1158/1078-0432.22483050.v1

Chicago

Matthias Preusser, Roger Stupp, Joerg C. Tonn, David A. Reardon, Burt Nabors, Thierry Gorlia, Michael Weber, Michael Weller, and Julia Furtner. 2023. “Supplementary Table 3 from Temporal Muscle Thickness as a Prognostic Marker in Patients with Newly Diagnosed Glioblastoma: Translational Imaging Analysis of the CENTRIC EORTC 26071–22072 and CORE Trials,” March. doi:10.1158/1078-0432.22483050.v1.